In response to the concerns over the link between Risperdal and Gynecomastia in minors, Andrus Wagstaff PC is investigating potential lawsuits for victims. The U.S. Food and Drug Administration in 2007 approved Risperdal (Risperdone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of […]
